These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 2562362

  • 1. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
    Sorice F, Vullo V, Cirelli A, Catania S, Mastroianni CM, Contini C, Delia S.
    Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
    [Abstract] [Full Text] [Related]

  • 2. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
    Filice G, Soldini L, Orsolini P, Razzini E, Gulminetti R, Campisi D, Chiapparoli L, Cattaneo E, Achilli G.
    Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
    [Abstract] [Full Text] [Related]

  • 3. Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1.
    Filice G, Cereda PM, Orsolini P, Soldini L, Romero E, Rondanelli EG.
    Microbiologica; 1990 Jul; 13(3):215-24. PubMed ID: 2125683
    [Abstract] [Full Text] [Related]

  • 4. Detection of antibodies to p24 and gp41 epitopes of HIV by ELISA using the recombinant core protein (p24) and envelope synthetic protein (gp41).
    Filice G, Soldini L, Orsolini P, Razzini E, Chiapparoli L, Gulminetti R, Cattaneo E, Achilli G.
    Microbiologica; 1991 Jan; 14(1):1-7. PubMed ID: 1906127
    [Abstract] [Full Text] [Related]

  • 5. [Prognostic significance of antibodies to HIV nuclear proteins in patients with the lymphadenopathy syndrome].
    Schulte C, Meurer M, Fröschl M.
    Hautarzt; 1988 Jan; 39(1):45-8. PubMed ID: 3162727
    [Abstract] [Full Text] [Related]

  • 6. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia].
    Kopecká D, Brůcková M, Stanková M, Syrůcek L, Vojtĕchovský K, Petkov V.
    Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline.
    Lange JM, de Wolf F, Krone WJ, Danner SA, Coutinho RA, Goudsmit J.
    AIDS; 1987 Sep; 1(3):155-9. PubMed ID: 3126756
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human monoclonal antibodies to HIV-1: cross-reactions with gag and env products.
    Pollock BJ, McKenzie AS, Kemp BE, McPhee DA, D'Apice AJ.
    Clin Exp Immunol; 1989 Dec; 78(3):323-8. PubMed ID: 2482145
    [Abstract] [Full Text] [Related]

  • 13. Decline of anti-p24 antibody precedes antigenaemia as correlate of prognosis in HIV-1 infection.
    Forster SM, Osborne LM, Cheingsong-Popov R, Kenny C, Burnell R, Jeffries DJ, Pinching AJ, Harris JR, Weber JN.
    AIDS; 1987 Dec; 1(4):235-40. PubMed ID: 3126771
    [Abstract] [Full Text] [Related]

  • 14. [HIV serological parameters in the prognosis and follow-up assessment of an HIV infection].
    Grob PJ, Joller-Jemelka H, Lüthy R, Täuber M, Ledergerber B, Brühwiler J, Fierz W.
    Schweiz Med Wochenschr; 1988 Jan 16; 118(2):58-64. PubMed ID: 3422761
    [Abstract] [Full Text] [Related]

  • 15. [Diagnostic value of antibodies against HIV-1 proteins in seropositive drug addicts tested by the western blotting method].
    Swiderska H, Kalinowska B.
    Przegl Epidemiol; 1992 Jan 16; 46(1-2):19-25. PubMed ID: 1475386
    [Abstract] [Full Text] [Related]

  • 16. Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users.
    Rezza G, Titti F, Pezzotti P, Sernicola L, Lo Caputo S, Angarano G, Lazzarin A, Sinicco A, Rossi GB, Verani P.
    J Biol Regul Homeost Agents; 1992 Jan 16; 6(1):15-20. PubMed ID: 1359736
    [Abstract] [Full Text] [Related]

  • 17. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.
    Zwart G, van der Hoek L, Valk M, Cornelissen MT, Baan E, Dekker J, Koot M, Kuiken CL, Goudsmit J.
    Virology; 1994 Jun 16; 201(2):285-93. PubMed ID: 7514319
    [Abstract] [Full Text] [Related]

  • 18. [HIV infection and T-lymphocyte behavior: results of a study in Palermo].
    Cangelosi C, Giardina RA, Pecoraro G, Marcianò R, Vitale MG, Gullotti A, Caronia F, Spanò C.
    Ann Ig; 1989 Jun 16; 1(1-2):45-50. PubMed ID: 2483080
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection.
    Janvier B, Mallet F, Cheynet V, Dalbon P, Vernet G, Besnier JM, Choutet P, Goudeau A, Mandrand B, Barin F.
    J Acquir Immune Defic Syndr (1988); 1993 Aug 16; 6(8):898-903. PubMed ID: 8315575
    [Abstract] [Full Text] [Related]

  • 20. Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers.
    Pincus SH, Messer KG, Nara PL, Blattner WA, Colclough G, Reitz M.
    J Clin Invest; 1994 Jun 16; 93(6):2505-13. PubMed ID: 7515393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.